Punjab Adopts NAT and CLIA to Advance Blood Safety
The Government of Punjab is upgrading its transfusion framework to implement advanced blood safety testing across all licensed blood centres. Consequently, the state is integrating Nucleic Acid Testing (NAT) and Chemiluminescence Immunoassay (CLIA) to identify transfusion-transmitted infections earlier. Dr Balbir Singh announced these reforms to minimize diagnostic window periods for HIV, hepatitis B, and hepatitis C.
Modernizing Blood Safety Testing with NAT and CLIA
Serological screening methods often struggle during the initial viral eclipse phase. Therefore, introducing NAT and CLIA addresses critical vulnerabilities in routine blood screening protocols. NAT directly amplifies viral genetic material to significantly shorten the detection window. Meanwhile, CLIA provides enhanced automated sensitivity compared to traditional ELISA platforms. As a result, these complementary technologies substantially minimize the residual risk of infectious transmission to recipients.
Standardized Guidelines and Operational Infrastructure
To maintain quality, the Health Department issued standardized guidelines for collection, labelling, and cross-matching across all 201 licensed centres. Furthermore, the state collected over 5.4 lakh blood units in 2025–26, achieving a voluntary donation rate of 96.04%. Additionally, authorities are establishing digital directories of voluntary donors to streamline emergency mobilization. Currently, 17 blood centres operate modern apheresis units, with rapid expansion planned across all remaining districts.
Expanding Clinical Transplants and Preventive Health
Alongside blood safety initiatives, the state is expanding organ donation capabilities. For example, the Punjab Institute of Liver and Biliary Sciences (PILBS) recently completed three successful liver transplants within 15 days. Moreover, PILBS plans to launch kidney transplant services shortly. In addition, the health department is collaborating with Punjab Agricultural University to issue targeted dietary advisories aimed at eliminating anemia among young women.
Frequently Asked Questions
Q1: Why is NAT considered superior to standard serological screening in blood banking?
NAT detects viral RNA and DNA directly rather than relying on host antibody responses. Consequently, it significantly narrows the diagnostic window period during acute viral infections.
Q2: How does CLIA enhance the efficacy of blood donor screening?
CLIA utilizes chemiluminescent labels to achieve higher analytical sensitivity and high-throughput automation. Therefore, it reduces false-negative results during routine infectious disease screening.
Q3: What regulatory steps is Punjab taking to ensure uniform transfusion safety?
The state has established standardized protocols for blood collection, barcoded labeling, and digital donor registries across 201 licensed centres to ensure complete traceability.
References
- Punjab moves to advanced NAT, CLIA testing to strengthen blood safety - ETHealthworld
- Comparative analysis of NAT reactivity and CLIA in detecting transfusion transmitted Infection among blood donors - PMC
- Nucleic acid testing: Is it the only answer for safe Blood in India? - PMC
